Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
45.63
-0.08 (-0.18%)
Aug 22, 2025, 3:04 PM CST

Huadong Medicine Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Net Income
3,6313,5122,8392,4992,3022,820
Upgrade
Depreciation & Amortization
972.73840.83809.56705.55591.56431
Upgrade
Other Amortization
29.6723.939.696.655.968.54
Upgrade
Loss (Gain) From Sale of Assets
16.595.46-4.32-8.260.03-322.64
Upgrade
Asset Writedown & Restructuring Costs
15.9525.195.14-22.68.022.51
Upgrade
Loss (Gain) From Sale of Investments
110.0382.8202.15115.6252.917.93
Upgrade
Provision & Write-off of Bad Debts
138.2112.1825.7668.6941.6922.83
Upgrade
Other Operating Activities
35.0587.18121.32137.61132.51179.92
Upgrade
Change in Accounts Receivable
-1,052-1,980-968.97-2,095-775.57-530.3
Upgrade
Change in Inventory
-28.41-498.85213.85-491.5218.09-37.73
Upgrade
Change in Accounts Payable
77.791,566685.551,450770.58797.16
Upgrade
Change in Other Net Operating Assets
13.1420.9843.017.24-4.9
Upgrade
Operating Cash Flow
3,9313,7493,9292,3823,1703,411
Upgrade
Operating Cash Flow Growth
-6.03%-4.59%64.96%-24.86%-7.08%70.43%
Upgrade
Capital Expenditures
-1,858-1,728-1,607-1,193-819.1-1,473
Upgrade
Sale of Property, Plant & Equipment
23.6319.7610.8515.4379.16373.81
Upgrade
Cash Acquisitions
-462.63-620.24-134.06-415.09-819.6-
Upgrade
Divestitures
-----113.37-
Upgrade
Investment in Securities
195.94112.84-115.24-948.91-357.5-629.8
Upgrade
Other Investing Activities
-191.2845.2394.52106.243.72-9.66
Upgrade
Investing Cash Flow
-2,293-2,170-1,751-2,436-1,987-1,739
Upgrade
Long-Term Debt Issued
-5,2514,8764,9752,2592,211
Upgrade
Total Debt Issued
4,2395,2514,8764,9752,2592,211
Upgrade
Long-Term Debt Repaid
--4,263-5,729-4,653-2,405-2,278
Upgrade
Total Debt Repaid
-4,377-4,263-5,729-4,653-2,405-2,278
Upgrade
Net Debt Issued (Repaid)
-137.8987.92-852.43322.13-146.03-67.22
Upgrade
Issuance of Common Stock
--10.63104.65--
Upgrade
Repurchase of Common Stock
-6.3-4.13----
Upgrade
Common Dividends Paid
-1,680-1,702-594.21-576.49-460.11-565.73
Upgrade
Other Financing Activities
28.24-31.2842.6650.01-161.31-92.78
Upgrade
Financing Cash Flow
-1,796-749.66-1,393-99.71-767.45-725.73
Upgrade
Foreign Exchange Rate Adjustments
-158.06-475.95-9.777.11-21.44
Upgrade
Net Cash Flow
-315.93781.99791.25-163.23422.73925.64
Upgrade
Free Cash Flow
2,0722,0212,3231,1892,3511,938
Upgrade
Free Cash Flow Growth
-17.62%-12.98%95.40%-49.44%21.26%199.03%
Upgrade
Free Cash Flow Margin
4.86%4.82%5.72%3.15%6.80%5.75%
Upgrade
Free Cash Flow Per Share
1.181.151.330.681.341.11
Upgrade
Cash Interest Paid
---0.620.95-
Upgrade
Cash Income Tax Paid
2,6652,5632,5523,0181,5392,165
Upgrade
Levered Free Cash Flow
607.511,2341,862604.482,1041,160
Upgrade
Unlevered Free Cash Flow
667.591,2941,934679.512,1471,203
Upgrade
Change in Working Capital
-1,019-940.75-78.95-1,12135.45261.49
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.